Treatments

Ultrasound Guided Penile Filler

Ultrasound Guided Penile Filler

Ultrasound-guided penile filler is the most advanced technique available for male enhancement, using real-time medical imaging to improve both safety and precision.

At Androfill, we use high-resolution ultrasound to visualise anatomy during the procedure, allowing controlled, accurate placement of filler for natural-looking results. Using the latest ultrasound imaging technology, the Esaote MyLab A50 enables real-time visualisation of anatomy, improving both safety and results.

At Androfill, we use medical-grade ultrasound imaging to guide every step of the procedure.

Image of an Esaote MyLab A50 Ultrasound Machine for Penile Filler Procedures

Why Ultrasound Guidance Matters

The penis contains several critical anatomical structures that must not be disturbed during a filler procedure. Ultrasound guidance allows the clinician to work with a clear, live image throughout.

  • Precise layer placement — filler is deposited in the correct plane between the dartos fascia and Buck’s fascia
  • Vascular mapping before injection — blood vessels are identified with Doppler imaging before any cannula is introduced
  • Real-time filler tracking — the clinician sees filler spreading live and adjusts accordingly
  • Reduced risk of injury — the dorsal neurovascular bundle and deep dorsal vein are visualised and avoided

The penis comprises, from superficial to deep: skin, dartos fascia, Buck’s fascia, the tunica albuginea, and the corpora cavernosa and corpus spongiosum. The correct injection plane is the sub-dartos space — between the dartos fascia and Buck’s fascia. This plane lies superficial to the dorsal neurovascular bundle, allowing circumferential filler distribution and minimising the risk of intravascular injection or nerve compression.

How Ultrasound Improves Safety

Avoiding Blood Vessels and Nerves

Before any injection, the Esaote MyLab A50 maps every blood vessel using Colour Doppler mode.

Correct Layer Placement

Even experienced clinicians cannot feel the difference between fascial layers by touch alone. Ultrasound makes this distinction visible.

Real-Time Filler Monitoring

As filler is injected, the clinician watches its spread on the ultrasound screen. Asymmetry is visible immediately and correctable in the same session.

In a study by Teixeira (2025), vascular mapping with Doppler ultrasound was performed in 503 consecutive patients, resulting in zero vascular complications. On B-mode ultrasound, HA filler appears hyperechoic, immediately visible as it spreads within the sub-dartos plane. A 2025 study in Cureus emphasises that correct injection depth is the single most critical variable for safe outcomes.

What Happens During the Procedure

  1. Consultation and consent — Your clinician reviews your history and discusses expectations.
  2. Pre-procedure ultrasound scan — Anatomy is examined and blood vessels mapped using Colour Doppler.
  3. Local anaesthesia — Topical cream followed by local anaesthetic injection.
  4. Cannula insertion under ultrasound — A fine cannula is guided into the correct sub-dartos plane.
  5. Filler injection with real-time monitoring — HA filler is injected using a fanning technique under live imaging.
  6. Post-injection symmetry scan — Ultrasound confirms even distribution.
  7. Post-procedure review — Aftercare and follow-up arranged.

Doppler assessment: B-mode imaging identifies fascial layers while Colour Doppler documents the dorsal artery pair and deep dorsal vein. Anaesthesia: A penile ring block with lidocaine and adrenaline provides comfort and vasoconstriction. Cannula insertion: A 22G blunt-tip microcannula is introduced at the 10 and 2 o’clock positions. Fanning technique: Filler is deposited in small aliquots as the cannula is withdrawn and re-angled radially for circumferential coverage.

The Evidence

Hyaluronic acid penile filler is the most studied injectable approach to penile girth enhancement:

  • A review of 471 men (Journal of Urology, 2024) found all complications were minor, with 0.42% infection rate and 0.63% granuloma rate.
  • A randomised controlled trial (Moon et al., 2021, n=64) showed mean girth increase of 22.74 mm at 24 weeks with no serious adverse events.
  • AUANews (2024) reports average girth increase of 1.8 cm across staged treatments, with durability up to 18 months.
  • A 2025 ultrasound-guided case study documented girth increase from 12.3 to 13.0 cm under continuous imaging with no complications.

AUA 2024 (n=471): Retrospective chart review, single institution. All complications Clavien-Dindo grade 1-2 only. Moon et al. 2021 RCT (n=64): Prospective, randomised, blinded trial. Mean girth increase 22.74 mm. No sexual function compromise. The ICSM 2024 recommends comprehensive pre-procedural assessment for all penile augmentation candidates.

Why Choose Androfill?

  • Unmatched experience — The world’s largest provider of penile filler procedures.
  • Ultrasound guidance as standard — Real-time imaging with the Esaote MyLab A50 is integral to every procedure.
  • Medical-grade imaging — Hospital-grade equipment with high-frequency linear probes and Colour Doppler.
  • Experienced urologists — Clinicians with specific expertise in male genital anatomy.
  • Hyaluronic acid only — Fully reversible with hyaluronidase. No permanent fillers or silicone.
  • Comprehensive patient journey — From pre-procedure ultrasound assessment through to follow-up scanning.
Dr Gary Horn

Author: Dr Gary Horn

GMC Registered Plastic Surgeon

Androfill Clinic Director

Dr Greta Peciulyte

Medically reviewed by: Dr Greta Peciulyte

GMC Registered Urologist

Androfill Clinical Team

As featured in the press

Superdrug Online Doctor articleThe Guardian — AndrofillBBC News — AndrofillThe Sun — AndrofillDaily Mail — Androfill

Regulatory bodies & memberships

British Association of Urological Surgeons (BAUS)General Medical CouncilTop DoctorsCosmetic Redress SchemeInternational Society of Aesthetic Plastic SurgeryPhalloboards Approved Practitioner

This website is for Androfill United Kingdom

Click below for Australia, Belgium, Canada, India, Israel, New Zealand, the Philippines, Saudi Arabia, Sweden, Switzerland, UAE and USA

Written and medically reviewed by Dr Gary Horn — consultant plastic and reconstructive surgeon, GMC 4267803. Reviewed by Dr Greta Peciulyte, Urologist, GMC 7539240. Last reviewed 28 August 2026. General information only, not a substitute for a consultation. Individual results vary.